Tracker Golimumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regulatory News: THERADIAG (ISIN: FR0004197747, Ticker: ALTER) (Paris:ALTER), a company specializing in in vitro diagnostics and Theranostics, today announces the launch of four additional kits in

Schleswig holsteinUnited statesFrance generalTheradiag optimabs infliximabPierre laurentDrug administrationFinancial communications investor relationsRegulatory newsTracker golimumabTracker anti golimumabTracker rituximabTracker anti rituximabFederal drug administrationOptimabs infliximabEuronext growth parisManaging director